| 发明名称 |
TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY |
| 摘要 |
A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product. |
| 申请公布号 |
US2016113972(A1) |
申请公布日期 |
2016.04.28 |
| 申请号 |
US201414895132 |
申请日期 |
2014.05.27 |
| 申请人 |
PROPREV AB |
发明人 |
BJÖRCK Inger;NILSSON Anne;BACKHED Fredrik;KOVATCHEVA-DATCHARY Petia |
| 分类号 |
A61K35/74 |
主分类号 |
A61K35/74 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. |
| 地址 |
Helsingborg SE |
